☰

Richard Mazurchuk - Publications

Affiliations: 
State University of New York, Buffalo, Buffalo, NY, United States 
Area:
General Biophysics, Medical Biophysics
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Srivastava S, Ghosh S, Kagan J, Mazurchuk R. The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities. Trends in Cancer. 4: 523-536. PMID 30064661 DOI: 10.1016/J.Trecan.2018.06.007  0.31
2012 Roy Chaudhuri T, Arnold RD, Yang J, Turowski SG, Qu Y, Spernyak JA, Mazurchuk R, Mager DE, Straubinger RM. Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation. Pharmaceutical Research. 29: 3312-24. PMID 22798260 DOI: 10.1007/S11095-012-0823-4  0.388
2010 Goswami LN, White WH, Spernyak JA, Ethirajan M, Chen Y, Missert JR, Morgan J, Mazurchuk R, Pandey RK. Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy. Bioconjugate Chemistry. 21: 816-27. PMID 20387863 DOI: 10.1021/Bc9005305  0.38
2010 Spernyak JA, White WH, Ethirajan M, Patel NJ, Goswami L, Chen Y, Turowski S, Missert JR, Batt C, Mazurchuk R, Pandey RK. Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapy. Bioconjugate Chemistry. 21: 828-35. PMID 20387862 DOI: 10.1021/Bc9005317  0.455
2009 Paul AK, Lobarinas E, Simmons R, Wack D, Luisi JC, Spernyak J, Mazurchuk R, Abdel-Nabi H, Salvi R. Metabolic imaging of rat brain during pharmacologically-induced tinnitus. Neuroimage. 44: 312-8. PMID 18948211 DOI: 10.1016/J.Neuroimage.2008.09.024  0.336
2008 Seshadri M, Bellnier DA, Vaughan LA, Spernyak JA, Mazurchuk R, Foster TH, Henderson BW. Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2796-805. PMID 18451247 DOI: 10.1158/1078-0432.Ccr-07-4705  0.382
2007 Seshadri M, Spernyak JA, Maiery PG, Cheney RT, Mazurchuk R, Bellnier DA. Visualizing the acute effects of vascular-targeted therapy in vivo using intravital microscopy and magnetic resonance imaging: correlation with endothelial apoptosis, cytokine induction, and treatment outcome. Neoplasia (New York, N.Y.). 9: 128-35. PMID 17356709 DOI: 10.1593/Neo.06748  0.429
2007 Pliss L, Mazurchuk R, Spernyak JA, Patel MS. Brain MR imaging and proton MR spectroscopy in female mice with pyruvate dehydrogenase complex deficiency. Neurochemical Research. 32: 645-54. PMID 17342409 DOI: 10.1007/S11064-007-9295-Z  0.329
2006 Seshadri M, Mazurchuk R, Spernyak JA, Bhattacharya A, Rustum YM, Bellnier DA. Activity of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid against human head and neck carcinoma xenografts. Neoplasia (New York, N.Y.). 8: 534-42. PMID 16867215 DOI: 10.1593/Neo.06295  0.559
2006 Lee KC, Hall DE, Hoff BA, Moffat BA, Sharma S, Chenevert TL, Meyer CR, Leopold WR, Johnson TD, Mazurchuk RV, Rehemtulla A, Ross BD. Dynamic imaging of emerging resistance during cancer therapy. Cancer Research. 66: 4687-92. PMID 16651420 DOI: 10.1158/0008-5472.Can-05-3205  0.355
2005 Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, Bernacki R, Rustum YM, Moossa AR, Hoffman RM. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Research. 65: 9829-33. PMID 16267005 DOI: 10.1158/0008-5472.Can-05-1548  0.357
2005 Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4241-50. PMID 15930363 DOI: 10.1158/1078-0432.Ccr-04-2703  0.46
2005 Mazurchuk R, Spernyak JA. Magnetic resonance imaging of tumor response to chemotherapy. Methods in Molecular Medicine. 111: 381-415. PMID 15911992 DOI: 10.1385/1-59259-889-7:381  0.405
2005 Li G, Slansky A, Dobhal MP, Goswami LN, Graham A, Chen Y, Kanter P, Alberico RA, Spernyak J, Morgan J, Mazurchuk R, Oseroff A, Grossman Z, Pandey RK. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjugate Chemistry. 16: 32-42. PMID 15656573 DOI: 10.1021/Bc049807X  0.488
2005 Torres G, Meeder BA, Hallas BH, Spernyak JA, Mazurchuk R, Jones C, Gross KW, Horowitz JM. Ventricular size mapping in a transgenic model of schizophrenia. Brain Research. Developmental Brain Research. 154: 35-44. PMID 15617753 DOI: 10.1016/J.Devbrainres.2004.08.011  0.307
2004 Bhattacharya A, Tóth K, Mazurchuk R, Spernyak JA, Slocum HK, Pendyala L, Azrak R, Cao S, Durrani FA, Rustum YM. Lack of microvessels in well-differentiated regions of human head and neck squamous cell carcinoma A253 associated with functional magnetic resonance imaging detectable hypoxia, limited drug delivery, and resistance to irinotecan therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8005-17. PMID 15585636 DOI: 10.1158/1078-0432.Ccr-04-1306  0.496
2004 Straubinger RM, Arnold RD, Zhou R, Mazurchuk R, Slack JE. Antivascular and antitumor activities of liposome-associated drugs. Anticancer Research. 24: 397-404. PMID 15152936  0.36
2004 Rajput A, Harrington R, Mazurchuk R, Humphrey L, Brattain M. Constitutive activation of EGFR results in a highly metastatic phenotype in an orthotopic model of colon cancer Journal of Surgical Research. 121: 308-309. DOI: 10.1016/J.Jss.2004.07.137  0.375
2002 Zhou R, Mazurchuk R, Straubinger RM. Antivasculature effects of doxorubicin-containing liposomes in an intracranial rat brain tumor model. Cancer Research. 62: 2561-6. PMID 11980650  0.396
1999 Mazurchuk R, Zhou R, Straubinger RM, Chau RI, Grossman Z. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: Implications for evaluation of tumor microvasculature and therapeutic response Magnetic Resonance Imaging. 17: 537-548. PMID 10231180 DOI: 10.1016/S0730-725X(98)00208-2  0.456
1997 Mazurchuk R, Glaves D, Raghavan D. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer Clinical Cancer Research. 3: 1635-1641. PMID 9815854  0.398
1993 Huang LR, Straubinger RM, Kahl SB, Koo MS, Alletto JJ, Mazurchuk R, Chau RI, Thamer SL, Fiel RJ. Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy. Journal of Magnetic Resonance Imaging : Jmri. 3: 351-6. PMID 8448397 DOI: 10.1002/Jmri.1880030210  0.43
1990 Fiel RJ, Musser DA, Mark EH, Mazurchuk R, Alletto JJ. A comparative study of manganese meso-sulfonatophenyl porphyrins: Contrast-enhancing agents for tumors Magnetic Resonance Imaging. 8: 255-259. PMID 2366638 DOI: 10.1016/0730-725X(90)90097-L  0.443
Show low-probability matches.